MEDBOX | Toolbox Substance Use Disorders, Others

Geffert,K., N. Rupp und S. Mauder MEDBOX (2020) CC

MEDBOX Issue Brief. No.5

Tags: Mental Health, COVID-19, MHPSS, Children, psychosocial support, stress,

Source: https://www.medbox.org/document/mental-h

Substance use considerations during #COVID19 (Arabic Version)

World Health Organization WHO; Regional Office for the Eastern Mediterreanan (2020) CC

Tags: substance use, COVID-19,

Source: http://www.emro.who.int/images/stories/m

Substance use considerations during #COVID19

World Health Organization WHO; Regional Office for the Eastern Mediterreanan (2020) CC

Tags: substance use, COVID-19,

Source: http://www.emro.who.int/images/stories/m

Mental Health in the times of COVID-19 Pandemic

National Institute of Mental Health & Neurosciences, Bengaluru India; Dept. of Psychiatry (2020) CC

Guidance for General Medical and Specialised Mental Health Care Settings

Tags: Mental Health, COVID-19, India, National Guidelines, Quarantine, suicide, stress, substance abuse,

Source: https://www.mohfw.gov.in/pdf/COVID19Fina

International standards for the treatment of drug use disorders - Revised Edition Incorporating Results Of Field - Testing

World Health Organization WHO (2020) C_WHO

This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementation of the Standards, in line with principles of public health care. The Standards identify major components and features of effective systems for the treatment of drug use disorders. They describe treatment modalities and interventions to match the needs of people at different stages and severities of drug use disorders, in a manner consistent with the treatment of any chronic disease or health condition. The Standards are aspirational, and such, national or local treatment services or systems need not attempt to meet all the standards and recommendations made in this document all at once. However over time, progressive quality improvement, with ‘evidence-based and ethical practice’ as an objective, can and should be expected to achieve better organized, more effective and ethical systems and services for people with drug use disorders

Tags: Standards, Treatment, drug use disorders, Drugs, settings, healthcare, treatment setting, interventions, health care needs,

Source: https://apps.who.int/iris/bitstream/hand

World Drug Report 2019 Booklet 1

United Nations Office on Drug and Crime UNODOC (2019) C1

The World Drug Report 2019 is again presented in five separate parts that divide the wealth of information and analysis contained in the report into individual reader-friendly booklets in which drugs are grouped by their psychopharmacological effect for the first time in the report’s history. Booklet 1 provides a summary of the four subsequent booklets by reviewing their key findings and highlighting policy implications based on their conclusions

Tags: mental health, substance abuse, Report, psychopharmacological effect, policy,

Source: https://wdr.unodc.org/wdr2019/

World Drug Report 2019 Booklet 5 Cannabis and Hallucinogens

United Nations Office on Drug and Crime UNODC (2019) C2

The World Drug Report 2019 is again presented in five separate parts that divide the wealth of information and analysis contained in the report into individual reader-friendly booklets in which drugs are grouped by their psychopharmacological effect for the first time in the report’s history. Booklet 5 contains a review of recent trends in the market for cannabis and for hallucinogens. The section on cannabis also includes a review of the latest developments in the jurisdictions that have adopted measures allowing the non-medical use of cannabis

Tags: cannabis, report, Hallucinogens, law, medical treatment,

Source: https://wdr.unodc.org/wdr2019/

European Drug Report 2019: trends and developments.

European Monitoring Centre for Drugs and Drug Addiction European Union (2019) C1

The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 European Drug Report package. Available in different languages: http://www.emcdda.europa.eu/publications/edr/trends-developments/2019_en

Tags: Europe, drug situation, Drug abuse, substance abuse, Report, data, Epidemiology, amphetamines, cannabis, cocaine, drug strategy, report,

Source: http://www.emcdda.europa.eu/publications

New psychoactive substances: challenges for drug surveillance, control, and public health responses

Peacock, a.; R. Bruno; N. Gisev, et al. (2019) C2

This paper looks at the increasing use of 'new psychoactive substances', a term which is defined differently by different people, but which is here defined as 'narcotic drugs or psychotropic substances made available or used from the early to mid-2000s for their psychoactive properties' Series: Series|Drug Use| Volume 394, ISSUE 10209, P1668-1684, November 02, 201

Tags: psychotropic substances, journal article,

Source: https://www.thelancet.com/journals/lance

World Drug Report 2019 Booklet 2 Global Overview of Drug Demand and Supply

United Nations Office on Drug and Crime UNODC (2019) C1

The World Drug Report 2019 is again presented in five separate parts that divide the wealth of information and analysis contained in the report into individual reader-friendly booklets in which drugs are grouped by their psychopharmacological effect for the first time in the report’s history. Booklet 2 contains a global overview of the latest estimates of and trends in the supply, use and health consequences of drugs

Tags: substance abuse, Supply, Report, Policy, global overview, global data,

Source: https://wdr.unodc.org/wdr2019/

	Mental Health & COVID-19 Geffert,K., N. Rupp und S. Mauder MEDBOX (2020) CC View PDF(89) Download (108) Add to my MEDBOX MEDBOX Issue Brief. No.5 Tags: Mental Health, COVID-19, MHPSS, Children, psychosocial support, stress, Source: https://www.medbox.org/document/mental-h
	Substance use considerations during #COVID19 (Arabic Version) World Health Organization WHO; Regional Office for the Eastern Mediterreanan (2020) CC View PDF(7) Download (9) Add to my MEDBOX Tags: substance use, COVID-19, Source: http://www.emro.who.int/images/stories/m
	Substance use considerations during #COVID19 World Health Organization WHO; Regional Office for the Eastern Mediterreanan (2020) CC View PDF(7) Download (11) Add to my MEDBOX Tags: substance use, COVID-19, Source: http://www.emro.who.int/images/stories/m
	Mental Health in the times of COVID-19 Pandemic National Institute of Mental Health & Neurosciences, Bengaluru India; Dept. of Psychiatry (2020) CC View PDF(25) Download (18) Add to my MEDBOX Guidance for General Medical and Specialised Mental Health Care Settings Tags: Mental Health, COVID-19, India, National Guidelines, Quarantine, suicide, stress, substance abuse, Source: https://www.mohfw.gov.in/pdf/COVID19Fina
	International standards for the treatment of drug use disorders - Revised Edition Incorporating Results Of Field - Testing World Health Organization WHO (2020) C_WHO View PDF(1) Download (0) Add to my MEDBOX This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementation of the Standards, in line with principles of public health care. The Standards identify major components and features of effective systems for the treatment of drug use disorders. They describe treatment modalities and interventions to match the needs of people at different stages and severities of drug use disorders, in a manner consistent with the treatment of any chronic disease or health condition. The Standards are aspirational, and such, national or local treatment services or systems need not attempt to meet all the standards and recommendations made in this document all at once. However over time, progressive quality improvement, with ‘evidence-based and ethical practice’ as an objective, can and should be expected to achieve better organized, more effective and ethical systems and services for people with drug use disorders Tags: Standards, Treatment, drug use disorders, Drugs, settings, healthcare, treatment setting, interventions, health care needs, Source: https://apps.who.int/iris/bitstream/hand
	World Drug Report 2019 Booklet 1 United Nations Office on Drug and Crime UNODOC (2019) C1 View PDF(38) Download (46) Add to my MEDBOX The World Drug Report 2019 is again presented in five separate parts that divide the wealth of information and analysis contained in the report into individual reader-friendly booklets in which drugs are grouped by their psychopharmacological effect for the first time in the report’s history. Booklet 1 provides a summary of the four subsequent booklets by reviewing their key findings and highlighting policy implications based on their conclusions Tags: mental health, substance abuse, Report, psychopharmacological effect, policy, Source: https://wdr.unodc.org/wdr2019/
	World Drug Report 2019 Booklet 5 Cannabis and Hallucinogens United Nations Office on Drug and Crime UNODC (2019) C2 View PDF(79) Download (43) Add to my MEDBOX The World Drug Report 2019 is again presented in five separate parts that divide the wealth of information and analysis contained in the report into individual reader-friendly booklets in which drugs are grouped by their psychopharmacological effect for the first time in the report’s history. Booklet 5 contains a review of recent trends in the market for cannabis and for hallucinogens. The section on cannabis also includes a review of the latest developments in the jurisdictions that have adopted measures allowing the non-medical use of cannabis Tags: cannabis, report, Hallucinogens, law, medical treatment, Source: https://wdr.unodc.org/wdr2019/
	European Drug Report 2019: trends and developments. European Monitoring Centre for Drugs and Drug Addiction European Union (2019) C1 View PDF(118) Download (33) Add to my MEDBOX The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 European Drug Report package. Available in different languages: http://www.emcdda.europa.eu/publications/edr/trends-developments/2019_en Tags: Europe, drug situation, Drug abuse, substance abuse, Report, data, Epidemiology, amphetamines, cannabis, cocaine, drug strategy, report, Source: http://www.emcdda.europa.eu/publications
	New psychoactive substances: challenges for drug surveillance, control, and public health responses Peacock, a.; R. Bruno; N. Gisev, et al. (2019) C2 Open external link (353) Add to my MEDBOX This paper looks at the increasing use of 'new psychoactive substances', a term which is defined differently by different people, but which is here defined as 'narcotic drugs or psychotropic substances made available or used from the early to mid-2000s for their psychoactive properties' Series: Series\|Drug Use\| Volume 394, ISSUE 10209, P1668-1684, November 02, 201 Tags: psychotropic substances, journal article, Source: https://www.thelancet.com/journals/lance
	World Drug Report 2019 Booklet 2 Global Overview of Drug Demand and Supply United Nations Office on Drug and Crime UNODC (2019) C1 View PDF(41) Download (42) Add to my MEDBOX The World Drug Report 2019 is again presented in five separate parts that divide the wealth of information and analysis contained in the report into individual reader-friendly booklets in which drugs are grouped by their psychopharmacological effect for the first time in the report’s history. Booklet 2 contains a global overview of the latest estimates of and trends in the supply, use and health consequences of drugs Tags: substance abuse, Supply, Report, Policy, global overview, global data, Source: https://wdr.unodc.org/wdr2019/

About MEDBOX

MEDBOX Video Series